Fischer Imaging has received FDA clearance to use its MammoTest digital breast biopsy system for interstitial breast brachytherapy.
Interstitial brachytherapy is a less-invasive, four-day alternative to the traditional six-week external-beam radiation therapy for breast tumors, according to the Denver-based firm. While traditional radiation therapy irradiates the entire breast, brachytherapy uses x-ray guidance, such as provided by the MammoTest system, to insert catheters for irradiation of the tissue within 2 cm of a lumpectomy site.
By AuntMinnie.com staff writers
December 2, 2004
Related Reading
Fischer grows revenues, settles with SEC, November 16, 2004
Road to RSNA, Fischer Imaging, November 10, 2004
Balloon brachytherapy suitable alternative to standard breast cancer radiation, June 15, 2004
Copyright © 2004 AuntMinnie.com
